Cash balance of A$49.2 million at 31 December 2025.

“In GA, light is not transduced into electrical signals because of a loss of photoreceptors, which leads to an absolute scotoma (blind spot). 2,3 The PRIMA neurostimulation system replaces the lost ...

Neuroinflammation represents a hallmark of many degenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, amyotrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

An Oklahoma man is in full remission after doctors diagnosed a rare autoimmune brain disease following years of unexplained symptoms and misdiagnoses. An estimated 25 to 30 million Americans live with ...

After years of misdiagnosis, Rod Fussinger was finally diagnosed with Anti-IgLON5 Associated Autoimmune Encephalitis, and ...

The tiny zebrafish is helping researchers rapidly determine whether a newborn’s genetic mutation is likely to cause spinal muscular atrophy (SMA), one of the leading causes of infant mortality ...

Footloose icon Kenny Loggins admits what he would like to see happen with Tom Cruise as he has one ongoing hope.

ABLi Therapeutics ("ABLi"), a biotechnology company developing therapeutics to address diseases that are associated with activation of Abelson Tyrosine Kinases (c-Abl kinases), announces it has ...

FDA approvals, trial progress and early commercial momentum put several ASX healthcare companies in a strong position heading into 2026. ... Read More The post ASX Quarterly Health Wrap: FDA ...

Researchers from Seoul National University Bundang Hospital focused on a condition called Isolated REM Sleep Behaviour Disorder, or iRBD. It affects an estimated two percent of older adults. iRBD ...